On September 18th, Gelonghui (002900.SZ) announced that the company held the 17th meeting of the fourth board of directors and the 14th meeting of the fourth board of supervisors on September 14, 2024, and approved the proposal on the termination of some capital-raising projects and the permanent replenishment of working capital with the remaining raised funds. Considering that the investment project "Pharmaceutical Production Base Construction Project", which was funded by the company's initial public offering of stocks, has reached the planned usable state, in order to improve the efficiency of the use of the raised funds, the company agreed to permanently replenish the remaining raised funds of 9.7326 million yuan into working capital.
哈三联(002900.SZ)：拟将“医药生产基地建设项目”结项 并将节余募资永久补充流动资金
Harbin Medisan Pharmaceutical (002900.SZ): Intends to settle the 'Medical Production Base Construction Project' and permanently supplement the remaining funds with working capital.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated